VLA 0.00% $1.75 viralytics limited

H1 2018 Results (Pending), page-2

  1. 15,334 Posts.
    lightbulb Created with Sketch. 684
    Viralytics is about to become a subsidiary of Merck

    there is almost no way this isn't going to happen Imo
    too much success has gone on with the combo trials too much business history

    even if this share had been trading at $1 its beyond doubtful premium would have been over 75c anyway - that is huge as it is

    crazy to set yourself up for disappointment ...time to find a new baby
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.